Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
Pace LE, Shulman LN. Breast cancer in sub-Saharan Africa: challenges and opportunities to reduce mortality. Oncologist. 2016;21(6):739.
Rambau P, Masalu N, Jackson K, Chalya P, Serra P, Bravaccini S. Triple negative breast cancer in a poor resource setting in North-Western Tanzania: a preliminary study of 52 patients. BMC Res Notes. 2014;7(1):1–6.
Mansouri H, Mnango LF, Magorosa EP, Sauli E, Mpolya EA. Ki-67, p53 and BCL-2 expressions and their association with clinical histopathology of breast cancer among women in Tanzania. Sci Rep. 2019;9(1):1–11.
Komen SG. Tanzania Breast Health Care Assessment: an assessment of breast cancer early detection, diagnosis and treatment in Tanzania. A report carried out on behalf of the Ministry of Health, Community Development, Gender, Elderly and Children of the United Republic of Tanzania.2017.
Simpson PT, Reis-Filho JS, Gale T, Lakhani SR. Molecular evolution of breast cancer. J Pathol J Pathol Soc Gr Brit Ire. 2005;205(2):248–54.
Algazzar MAA, Elsayed EE-M, Alhanafy AM, Mousa WA. Breast cancer imaging features as a predictor of the hormonal receptor status, HER2neu expression and molecular subtype. Egypt J Radiol Nucl Med. 2020;51(1):1–10.
Cho N. Molecular subtypes and imaging phenotypes of breast cancer. Ultrasonog. 2016;35(4):281.
Rakha EA, Green AR. Molecular classification of breast cancer: what the pathologist needs to know. Pathology. 2017;49(2):111–9.
Hadgu E, Seifu D, Tigneh W, Bokretsion Y, Bekele A, Abebe M, et al. Breast cancer in Ethiopia: evidence for geographic difference in the distribution of molecular subtypes in Africa. BMC Womens Health. 2018;18(1):1–8.
Seshie B, Adu-Aryee NA, Dedey F, Calys-Tagoe B, Clegg-Lamptey J-N. A retrospective analysis of breast cancer subtype based on ER/PR and HER2 status in Ghanaian patients at the Korle Bu Teaching Hospital, Ghana. BMC Clin Pathol. 2015;15(1):14.
Anothaisintawee T, Wiratkapun C, Lerdsitthichai P, Kasamesup V, Wongwaisayawan S, Srinakarin J, et al. Risk factors of breast cancer: a systematic review and meta-analysis. As Pac J Public Health. 2013;25(5):368–87.
Anderson KN, Schwab RB, Martinez ME. Reproductive risk factors and breast cancer subtypes: a review of the literature. Breast Cancer Res Treat. 2014;144(1):1–10.
Wang JM, Wang J, Zhao HG, Liu TT, Wang FY. Reproductive risk factors associated with breast cancer molecular subtypes among young women in Northern China. BioMed Res Int. 2020;2020:1–9.
Britton JA, Gammon MD, Schoenberg JB, Stanford JL, Coates RJ, Swanson CA, et al. Risk of breast cancer classified by joint estrogen receptor and progesterone receptor status among women 20–44 years of age. Am J Epidemiol. 2002;156(6):507–16.
Huang W-Y, Newman B, Millikan RC, Schell MJ, Hulka BS, Moorman PG. Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. Am J Epidemiol. 2000;151(7):703–14.
Williams LA, Casbas-Hernandez P, Nichols HB, Tse CK, Allott EH, Carey LA, et al. Risk factors for luminal a ductal carcinoma in situ (DCIS) and invasive breast cancer in the carolina breast cancer study. PLoS ONE. 2019;14(1):e0211488.
Brouckaert O, Rudolph A, Laenen A, Keeman R, Bolla MK, Wang Q, et al. Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study. Breast Cancer Res. 2017;19(1):1–12.
Sisti JS, Collins LC, Beck AH, Tamimi RM, Rosner BA, Eliassen AH. Reproductive risk factors in relation to molecular subtypes of breast cancer: results from the nurses’ health studies. Int J cancer. 2016;138(10):2346–56.
Lakhani SR, Ellis IO, Schnitt S, Tan PH, van de Vijver M. WHO classification of tumours of the breast. 2012.
Elston CW, Ellis IO. Pathological prognostic factors in breast cancer I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991;19(5):403–10.
Hammond MEH, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). Arc Pathol Lab Med. 2010;134(7):e48–72.
Edge SB, Byrd DR, Carducci MA, Compton CC, Fritz A, Greene F. AJCC cancer staging manual. New York: Springer; 2010.
Dey S, Soliman AS, Hablas A, Seifeldein IA, Ismail K, Ramadan M, et al. Urban–rural differences in breast cancer incidence in Egypt (1999–2006). Breast. 2010;19(5):417–23.
Errahhali ME, Errahhali ME, Ouarzane M, El Harroudi T, Afqir S, Bellaoui M. First report on molecular breast cancer subtypes and their clinico-pathological characteristics in Eastern Morocco: series of 2260 cases. BMC Womens Health. 2017;17(1):3.
Alnegheimish NA, Alshatwi RA, Alhefdhi RM, Arafah MM, AlRikabi AC, Husain S. Molecular subtypes of breast carcinoma in Saudi Arabia: a retrospective study. Saudi Med J. 2016;37(5):506.
Redondo CM, Gago-Domínguez M, Ponte SM, Castelo ME, Jiang X, García AA, et al. Breast feeding, parity and breast cancer subtypes in a Spanish cohort. PLoS ONE. 2012;7(7):e40543.
Mwakigonja AR, Lushina NE, Mwanga A. Characterization of hormonal receptors and human epidermal growth factor receptor-2 in tissues of women with breast cancer at Muhimbili National Hospital, Dar es salaam, Tanzania. Infect Agents Cancer. 2017;12(1):60.
Sawe RT, Mining SK, Ofulla AV, Patel K, Guyah B, Chumba D, et al. Tumor infiltrating leukocyte density is independent of tumor grade and molecular subtype in aggressive breast cancer of Western Kenya. Trop Med Health. 2017;45(1):19.
Brewster AM, Chavez-MacGregor M, Brown P. Epidemiology, biology, and treatment of triple-negative breast cancer in women of African ancestry. Lanc Oncol. 2014;15(13):e625–34.
Effi AB, Koui BS, Koffi KD, Traore ZC, Kouyate M. Breast cancer molecular subtypes defined by ER/PR and HER2 status: association with clinicopathologic parameters in Ivorian patients. As Pac J Cancer Prev. 2016;17(4):1973–8.
Nafissi N, Faraji M, Hosseini M, Shojaee L, Ziaei F, Akbari ME, et al. Relationships between reproductive risk factors for breast cancer and tumor molecular subtypes. As Pac J Cancer Prev. 2018;19(7):1767.
Al-Thoubaity FK. Molecular classification of breast cancer: a retrospective cohort study. Ann Med Surg. 2020;49:44–8.
Belhadj A, Addou-Klouche L, Benyelles MK, Bendaoud A, Ziane I, Zakmout B, et al. Epidemiological study and molecular breast cancer subtypes distribution among West Algerian patients. J Int Res Med Pharm Sci. 2016;6:18–24.
Turkoz FP, Solak M, Petekkaya I, Keskin O, Kertmen N, Sarici F, et al. Association between common risk factors and molecular subtypes in breast cancer patients. Breast. 2013;22(3):344–50.
Lambertini M, Santoro L, Del Mastro L, Nguyen B, Livraghi L, Ugolini D, et al. Reproductive behaviors and risk of developing breast cancer according to tumor subtype: a systematic review and meta-analysis of epidemiological studies. Cancer Treat Rev. 2016;49:65–76.
Dall GV, Britt KL. Estrogen effects on the mammary gland in early and late life and breast cancer risk. Front Oncol. 2017;7:110.
Lambe M, Hsieh C, Trichopoulos D, Ekbom A, Pavia M, Adami H-O. Transient increase in the risk of breast cancer after giving birth. N Engl J Med. 1994;331(1):5–9.
Romieu I, Biessy C, Carayol M, His M, Torres-Mejía G, Ángeles-Llerenas A, et al. Reproductive factors and molecular subtypes of breast cancer among premenopausal women in Latin America: the PRECAMA study. Sci Rep. 2018;8(1):1–10.
Dianatinasab M, Fararouei M, Daneshi N, Rezaian S, Mohammadianpanah M, Chaman R, et al. Heterogeneity in risk factors for ductal and lobular breast carcinomas: a case–control study. Int J Cancer. 2019;145(11):2917–25.
Milne RL, Gaudet MM, Spurdle AB, Fasching PA, Couch FJ, Benítez J, et al. Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study. Breast Cancer Res. 2010;12(6):1–11.
Holm J, Eriksson L, Ploner A, Eriksson M, Rantalainen M, Li J, et al. Assessment of breast cancer risk factors reveals subtype heterogeneity. Cancer Res. 2017;77(13):3708–17.
Sayed S, Fan S, Moloo Z, Wasike R, Bird P, Saleh M, et al. Breast Cancer risk factors in relation to molecular subtypes in breast cancer patients from Kenya. 2021.
Victora CG, Bahl R, Barros AJ, França GV, Horton S, Krasevec J, et al. Breast-feeding in the 21st century: epidemiology, mechanisms, and lifelong effect. Lancet. 2016;387(10017):475–90.
Russo J, Hu YF, Yang X, Russo IH. Developmental, cellular, and molecular basis of human breast cancer. JNCI Monogr. 2000;2000(27):17–37.
John EM, Hines LM, Phipps AI, Koo J, Longacre TA, Ingles SA, et al. Reproductive history, breast-feeding and risk of triple negative breast cancer: the breast cancer etiology in minorities (BEM) study. Int J Cancer. 2018;142(11):2273–85.
Wunderle M, Pretscher J, Brucker SY, Volz B, Hartmann A, Fiessler C, et al. Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancer. Breast Cancer Res Treat. 2019;174(2):453–61.
Devi CB, Tang TS, Corbex M. Incidence and risk factors for breast cancer subtypes in three distinct South-East Asian ethnic groups: Chinese, Malay and natives of Sarawak. Malaysia Int J cancer. 2012;131(12):2869–77.
Fourati A, Boussen H, El May MV, Goucha A, Dabbabi B, Gamoudi A, et al. Descriptive analysis of molecular subtypes in Tunisian breast cancer. Asia Pac J Clin Oncol. 2014;10(2):e69–74.
Elgasim MAEA, Abusin HM, Nouri MM. Breast cancer molecular subtypes in relation to age, stage and grade among Sudanese women patients in Khartoum oncology hospital (2013–2017). Int Res J Oncol. 2019;2:1–9.
Sengal AT, Haj-Mukhtar NS, Elhaj AM, Bedri S, Kantelhardt EJ, Mohamedani AA. Immunohistochemistry defined subtypes of breast cancer in 678 Sudanese and Eritrean women; hospitals based case series. BMC Cancer. 2017;17(1):804.
Chukwuma UJ, Arinze NM, Thaddeus ON, Kenneth EC, Felix EO, Chudi OO, et al. The histological subtypes of breast cancer seen in a tertiary hospital in South-East, Nigeria. Glob J Health Sci. 2020;12(6):93.
Iliyasu Y, Atanda AT. Molecular subtyping of carcinoma of the female breast in a tertiary teaching hospital in Northern Nigeria. Ann Trop Pathol. 2019;10(1):20.
Omoruyi KA, Nnoli MA, Ebughe GA, Irabor GI, Isiwele EM. Prevalence of molecular subtypes of breast carcinoma in University of Calabar Teaching Hospital using immunohistochemistry as surrogates for intrinsic DNA gene characteristics. 2018.
Aman NA, Doukoure B, Koffi KD, Koui BS, Traore ZC, Kouyate M, et al. HER2 overexpression and correlation with other significant clinicopathologic parameters in Ivorian breast cancer women. BMC Clin Pathol. 2019;19(1):1–6.
Traoré B, Koulibaly M, Diallo A, Bah M. Molecular profile of breast cancers in Guinean oncological settings. Pan Afr Med J. 2019. https://doi.org/10.11604/pamj.2019.33.22.18189.
Ly M, Antoine M, Dembélé AK, Levy P, Rodenas A, Touré BA, et al. High incidence of triple-negative tumors in sub-saharan Africa: a prospective study of breast cancer characteristics and risk factors in Malian women seen in a Bamako university hospital. Oncology. 2012;83(5):257–63.
Mvila GL, Batalansi D, Praet M, Marchal G, Laenen A, Christiaens M-R, et al. Prognostic features of breast cancer differ between women in the Democratic Republic of Congo and Belgium. Breast. 2015;24(5):642–8.
Miguel F, Lopes LV, Ferreira E, Ribas E, Pelaez AF, Leal C, et al. Breast cancer in Angola, molecular subtypes: a first glance. Ecancer Med Sci. 2017. https://doi.org/10.3332/ecancer.2017.763.
McCormack VA, Joffe M, van den Berg E, Broeze N, dos Santos SI, Romieu I, et al. Breast cancer receptor status and stage at diagnosis in over 1,200 consecutive public hospital patients in Soweto, South Africa: a case series. Breast Cancer Res. 2013;15(5):R84.
Bhatia RK, Narasimhamurthy M, Martei YM, Prabhakar P, Hutson J, Chiyapo S, et al. Report of clinico-pathological features of breast cancer in HIV-infected and uninfected women in Botswana. Infect Agents Cancer. 2019;14(1):28.
Galukande M, Wabinga H, Mirembe F, Karamagi C, Asea A. Molecular breast cancer subtypes prevalence in an indigenous Sub Saharan African population. Pan Afr Med J. 2014. https://doi.org/10.11604/pamj.2014.17.249.3305.